+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Short-read Sequencing Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • PDF Icon

    Report

  • 206 Pages
  • February 2024
  • Region: Global
  • Infogence Global Research
  • ID: 5669503

Rise in concern for genetic diseases, expansion of pharmaceutical and biotechnology companies, and improved healthcare infrastructure positively affects the short read sequencing market. Furthermore, use of advanced genetic treatments extend profitable opportunity to the market players

The Global Short-read Sequencing Market is estimated to be USD 10.15 Bn in 2023 and is expected to reach USD 17.43 Bn by 2028 growing at a CAGR of 11.42%

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global Short-read Sequencing Market is segmented based on Technology, Products, Workflow, Application, End-Users, and Geography.
  • By Technology, the market is classified into Next-Generation Sequencing, and Sanger Sequencing.
  • By Products, the market is classified into Consumables, Instruments, and Services.
  • By Workflow, the market is classified into Data Analysis, Pre-Sequencing, and Sequencing.
  • By Application, the market is classified into Agrigenomics & Forensics, Clinical Investigation, Consumer Genomics, HLA Typing/Immune System Monitoring, MetAgenomics, Epidemiology & Drug Development, and Oncology, Reproductive Health.
  • By End-Users, the market is classified into Academic Research, Clinical Research, Hospitals & Clinics, and Pharma & Biotech Entities.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are 10x Genomics, Inc., Agilent Technologies, Inc., BGI Genomics, Cardinal Health, Inc., Eurofins Genomics LLC, F. Hoffmann-La Roche Ag, Fasteris SA, GE Healthcare, GENEWIZ, Inc., etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Short-read Sequencing Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Short-read Sequencing Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Short-read Sequencing Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 LanguAge
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Rising Demand for Personalized Medicine and Companion Diagnostics
4.1.2 Increasing Demand Attributed to Low-Cost Sequencing in Detection of Unknown Genetic Variants in Clinical Research
4.1.3 Surge in Demand from Application Areas Such as Oncology, Infectious Disease, Reproductive Screening, and Pharmacogenomics
4.2 Restraints
4.2.1 ShortAge of Skilled Professionals and High Cost
4.3 Opportunities
4.3.1 Ongoing Developments to Decrease the Cost of Genome Sequencing
4.3.2 Growing Collaboration for Genetic Sequencing
4.4 Challenges
4.4.1 Dearth of Required Infrastructure in Emerging Economies
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
5.5 PESTLE Analysis
6 Global Short-read Sequencing Market, By Technology
6.1 Introduction
6.2 Next-Generation Sequencing
6.3 Sanger Sequencing
7 Global Short-read Sequencing Market, By Products
7.1 Introduction
7.2 Consumables
7.3 Instruments
7.4 Services
8 Global Short-read Sequencing Market, By Workflow
8.1 Introduction
8.2 Data Analysis
8.3 Pre-Sequencing
8.4 Sequencing
9 Global Short-read Sequencing Market, By Application
9.1 Introduction
9.2 Agrigenomics & Forensics
9.3 Clinical Investigation
9.4 Consumer Genomics
9.5 HLA Typing/Immune System Monitoring
9.6 MetAgenomics, Epidemiology & Drug Development
9.7 Oncology
9.8 Reproductive Health
10 Global Short-read Sequencing Market, By End-Users
10.1 Introduction
10.2 Academic Research
10.3 Clinical Research
10.4 Hospitals & Clinics
10.5 Pharma & Biotech Entities
11 Americas’ Short-read Sequencing Market
11.1 Introduction
11.2 Argentina
11.3 Brazil
11.4 Canada
11.5 Chile
11.6 Colombia
11.7 Mexico
11.8 Peru
11.9 United States
11.10 Rest of Americas
12 Europe’s Short-read Sequencing Market
12.1 Introduction
12.2 Austria
12.3 Belgium
12.4 Denmark
12.5 Finland
12.6 France
12.7 Germany
12.8 Italy
12.9 Netherlands
12.10 Norway
12.11 Poland
12.12 Russia
12.13 Spain
12.14 Sweden
12.15 Switzerland
12.16 United Kingdom
12.17 Rest of Europe
13 Middle East and Africa’s Short-read Sequencing Market
13.1 Introduction
13.2 Egypt
13.3 Israel
13.4 Qatar
13.5 Saudi Arabia
13.6 South Africa
13.7 United Arab Emirates
13.8 Rest of MEA
14 APAC’s Short-read Sequencing Market
14.1 Introduction
14.2 Australia
14.3 Bangladesh
14.4 China
14.5 India
14.6 Indonesia
14.7 Japan
14.8 Malaysia
14.9 Philippines
14.10 Singapore
14.11 South Korea
14.12 Sri Lanka
14.13 Thailand
14.14 Taiwan
14.15 Rest of Asia-Pacific
15 Competitive Landscape
15.1 Competitive Quadrant
15.2 Market Share Analysis
15.3 Strategic Initiatives
15.3.1 M&A and Investments
15.3.2 Partnerships and Collaborations
15.3.3 Product Developments and Improvements
16 Company Profiles
16.1 10x Genomics, Inc.
16.2 Agilent Technologies, Inc.
16.3 BGI Genomics
16.4 Cardinal Health, Inc.
16.5 Eurofins Genomics, LLC
16.6 F. Hoffmann-La Roche Ag
16.7 Fasteris SA
16.8 GE Healthcare
16.9 GENEWIZ, Inc.
16.10 Genexa Ag
16.11 Genscript Biotech Corp.
16.12 Illumina, Inc.
16.13 Macrogen, Inc.
16.14 Medline Industries, LP
16.15 Thermo Fisher Scientific, Inc.
16.16 Oxford Nanopore Technologies
16.17 PerkinElmer, Inc.
16.18 QIAGEN GmbH
16.19 Seven Bridges Genomics, Inc.
17 Appendix
17.1 Questionnaire

Companies Mentioned

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • BGI Genomics
  • Cardinal Health, Inc.
  • Eurofins Genomics, LLC
  • F. Hoffmann-La Roche Ag
  • Fasteris SA
  • GE Healthcare
  • GENEWIZ, Inc.
  • Genexa Ag
  • Genscript Biotech Corp.
  • Illumina, Inc.
  • Macrogen, Inc.
  • Medline Industries, LP
  • Oxford Nanopore Technologies
  • PerkinElmer, Inc.
  • QIAGEN GmbH
  • Seven Bridges Genomics, Inc.
  • Thermo Fisher Scientific, Inc.

Table Information